Ethanol metabolism results in a G2/M cell-cycle arrest in recombinant Hep G2 cells
Corresponding Author
Dahn L. Clemens Ph.D.
Department of Internal Medicine, University of Nebraska Medical Center and Veterans Administration Medical Center, Omaha, NE
Research Service, R151, Veterans Administration Medical Center, 4101 Woolworth Ave., Omaha, NE 68105. fax: 402-449-0604===Search for more papers by this authorLilian E. Calisto
Department of Internal Medicine, University of Nebraska Medical Center and Veterans Administration Medical Center, Omaha, NE
Search for more papers by this authorMichael F. Sorrell
Department of Internal Medicine, University of Nebraska Medical Center and Veterans Administration Medical Center, Omaha, NE
Search for more papers by this authorDean J. Tuma
Department of Internal Medicine, University of Nebraska Medical Center and Veterans Administration Medical Center, Omaha, NE
Search for more papers by this authorCorresponding Author
Dahn L. Clemens Ph.D.
Department of Internal Medicine, University of Nebraska Medical Center and Veterans Administration Medical Center, Omaha, NE
Research Service, R151, Veterans Administration Medical Center, 4101 Woolworth Ave., Omaha, NE 68105. fax: 402-449-0604===Search for more papers by this authorLilian E. Calisto
Department of Internal Medicine, University of Nebraska Medical Center and Veterans Administration Medical Center, Omaha, NE
Search for more papers by this authorMichael F. Sorrell
Department of Internal Medicine, University of Nebraska Medical Center and Veterans Administration Medical Center, Omaha, NE
Search for more papers by this authorDean J. Tuma
Department of Internal Medicine, University of Nebraska Medical Center and Veterans Administration Medical Center, Omaha, NE
Search for more papers by this authorAbstract
Previous studies using the Hep G2-based VA cells showed that ethanol metabolism resulted in both cytotoxicity and impaired DNA synthesis, causing reduced accumulation of cells in culture. To further characterize the ethanol oxidation-mediated impairment of DNA synthesis we analyzed the cell-cycle progression of VA cells. These studies showed approximately a 6-fold increase in the percentage of cells in the G2/M phase of the cell cycle after 4 days of ethanol exposure. The G2/M transition requires activity of the cyclin-dependent kinase, Cdc2. Cdc2 is positively regulated by association with cyclin B1, and negatively regulated by phosphorylation of amino acids Thr14 and Tyr15. Immunoblot analysis revealed that ethanol metabolism had little affect on total Cdc2 content in these cells, but resulted in the accumulation of up to 20 times the amount of cyclin B1, indicating that cyclin B1 was available for formation of Cdc2/cyclin B1 complexes. Co-immunoprecipitation revealed that 6 times more Cdc2/cyclin B1 complexes were present in the ethanol-treated cells compared with the controls. Investigation of the phosphorylation state of Cdc2 revealed that ethanol oxidation increased the amount of the phosphorylated inactive form of Cdc2 by approximately 3-fold. Thus, the impairment in cell-cycle progression could not be explained by a lack of cyclin B1, or the ability of Cdc2 and cyclin B1 to associate, but instead resulted, at least in part, from impaired Cdc2 activity. In conclusion, ethanol oxidation by VA cells results in a G2/M cell-cycle arrest, mediated by accumulation of the phosphorylated inactive form of Cdc2.
References
- 1 Crabb DW, Bosron WF, Li T-K. Ethanol metabolism. Pharmacol Ther 1987; 34: 59–73.
- 2 Teschke R, Gellert J. Hepatic microsomal ethanol-oxidizing system (MEOS): metabolic aspects and clinical implications. Alcohol Clin Exp Res 1986; 10(Suppl): 20S–32S.
- 3 Iimuro Y, Gallucci RM, Luster MI, Kono H, Thurman RG. Antibodies to tumor necrosis factor alpha attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 1997; 26: 1530–1537.
- 4 Dugauy L, Coutu D, Hetu C, Joly J-G. Inhibition of liver regeneration by chronic alcohol administration. Gut 1982; 23: 8–13.
- 5 Diehl AM, Chacon M, Wagner P. The effect of chronic ethanol feeding on ornithine decarboxylase activity and liver regeneration. Hepatology 1988; 8: 237–242.
- 6 Yang SQ, Lin HZ, Yin M, Albrecht JH, Diehl AM. Effects of chronic ethanol consumption on cytokine regulation of liver regeneration. Am J Physiol 1998; 275: G696–G704.
- 7 Lands WEM. Cellular signals in alcohol-induced liver injury: a review. Alcohol Clin Exp Res 1995; 19: 928–938.
- 8 Carter EA, Wands JR. Ethanol inhibits hormone stimulated hepatocyte DNA synthesis. Biochem Biophys Res Commun 1985; 128: 767–774.
- 9 Wands JR, Carter EA, Bucher NL, Isselbacher KJ. Inhibition of hepatic regeneration in rats by acute and chronic ethanol intoxication. Gastroenterology 1979; 77: 528–531.
- 10 Carter EA, Wands JR. Ethanol induced inhibition of liver cell function. 1. effect of ethanol on hormone stimulated hepatocyte DNA synthesis and the role of ethanol metabolism. Alcohol Clin Exp Res 1988; 12: 555–562.
- 11 Clemens DL, Forman A, Jerrells TR, Sorrell MF, Tuma DJ. Relationship between acetaldehyde levels and cell survival in ethanol-metabolizing hepatoma cells. Hepatology 2002; 35: 1196–1204.
- 12 Higgins PJ, Borenfreund E. Incubation of rat hepatic tumor cells with ethanol and acetaldehyde in vitro: effects on growth rate, albumin secretion and cellular protein content. Digestion 1986; 34: 161–168.
- 13 Higgins PJ, Borenfreund E. Alterations in growth rate and cell cycle kinetics of rat liver tumor cells cultured in ethanol-containing medium. Biochem Pharm 1986; 35: 3857–3862.
- 14 Knowles BB, Howe CC, Aden DP. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis surface antigens. Science 1980; 209: 497–499.
- 15 Donohue TM, Clemens DL, Galli A, Crabb D, Nieto N, Kato J, Barve SS. Use of cultured cells in assessing ethanol toxicity and ethanol-related metabolism. Alcohol Clin Exp Res 2001; 25: 87S–93S.
- 16 Grana X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin-dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 1995; 11: 211–219.
- 17 Nurse P. Universal control mechanism regulating onset of M-phase. Nature 1990; 344: 503–508.
- 18 Clemens DL, Halgard CM, Miles RM, Sorrell MF, Tuma DJ. Establishment of a recombinant hepatic cell line stably expressing alcohol dehydrogenase. Arch Biochem Biophys 1995; 321: 311–318.
- 19 Dai Y, Rashba-Stap J, Cedarbaum A. Stable expression of human cytochrome P4502E1 in HepG2 cells: characterization of catalytic activities and production of reactive oxygen intermediates. Biochem 1993; 32: 6928–6937.
- 20 Labarca C, Paigen K. A simple, rapid and sensitive DNA assay procedure. Anal Biochem 1980; 102: 344–352.
- 21 Vindelov LL. Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. A new method for rapid isolation and straining of nuclei. Virchows Arch 1977; 24: 227–242.
- 22 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685.
- 23 Payne DM, Rossomando AJ, Martino P, Erickson AK, Her JH, Shabanowitz J, Hunt DF, et al. Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase). EMBO J 1991; 10: 885–892.
- 24 Zimmermann S, Moelling K. Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 1999; 286: 1741–1744.
- 25 Vasioukhin V, Bauer C, Degenstein L, Wise B, Fuchs E. Hyperproliferation and defects in epithelial polarity upon conditional ablation of alpha-catenin in skin. Cell 2001; 104: 605–617.
- 26 Norbury C, Blow J, Nurse P. Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates. EMBO J 1991; 10: 3321–3329.
- 27 Atherton-Fessler S, Parker LL, Geahlen RL, Piwnica-Worms H. Mechanisms of p34cdc2 regulation. Mol Cell Biol 1993; 13: 1675–1685.
- 28 Fausto N. Liver regeneration. In: IM Arias, et al. eds. Liver Biology and Pathobiology. Philadelphia: Lippincott, Williams & Wilkins, 2001; 591–610.
- 29 Lewis TS, Shapiro PS, Ahn NG. Signal transduction through MAP kinase cascades. Adv Cancer Res 1998; 74: 49–139.
- 30 Morgan DO. Principles of CDK regulation. Nature 1995; 374: 131–134.
- 31 Pines J. Cyclins and cyclin-dependent kinases: a biochemical view. Biochem J 1995; 308: 697–711.
- 32 Draetta G, Luca F, Westendorf J, Brizuela L, Ruderman J, Beach D. Cdc2 protein kinase is complexed with both cyclin A and B: evidence for proteolytic inactivation of MPF. Cell 1989; 56: 829–838.
- 33 Gautier J, Minshull J, Lohka M, Glotzer M, Hunt T, Maller JL. Cyclin is a component of maturation-promoting factor from Xenopus. Cell 1990; 60: 487–494.
- 34 Sherr CJ. Mammalian G1 cyclins. Cell 1993; 73: 1059–1065.
- 35 Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999; 13: 1501–1512.
- 36 O'Rourke MF, Tuma DJ, Casey CA. Decreased binding and autophosphorylation of the epidermal growth factor receptor in ethanol-fed rats. Biochem Pharm 1997; 53: 1445–1450.
- 37 Nurse P. Checkpoint pathways come of age. Cell 1997; 91: 865–867.
- 38 Pines J, Hunter T. Human cell division: the involvement of cyclins A and B1, and multiple cdc2s. Cold Spring Harb Symp Quant Biol 1991; 56: 449–463.
- 39 Pines J, Hunter T. Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2. Cell 1989; 58: 833–846.
- 40 Pines J, Hunter T. Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B. Nature 1990; 346: 760–763.
- 41 Glotzer M, Murray AW, Kirschner MW. Cyclin is degraded by the ubiquitin pathway. Nature 1991; 349: 132–138.
- 42 Murray A. Cyclin ubiquitination: the destructive end of mitosis. Cell 1995; 81: 149–152.
- 43 Jin P, Gu Y, Morgan DO. Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells. J Cell Biol 1996; 134: 963–970.
- 44 Hoffmann I, Clarke PR, Marcote MJ, Karsenti E, Draetta G. Phosphorylation and activation of human cdc25-C by cdc2-cyclin B and its involvement in the self-amplification of MPF at mitosis. EMBO J 1993; 12: 53–63.
- 45 Wells NJ, Watanabe N, Tokusumi T, Jiang W, Verdecia MA, Hunter T. The C-terminal domain of the Cdc2 inhibitory kinase Myt1 interacts with Cdc2 complexes and is required for inhibition of G2/M progression. J Cell Sci 1999; 112: 3361–3371.
- 46 Atkinson KJ, Rao RK. Role of protein tyrosine phosphorylation in acetaldehyde-induced disruption of epithelial tight junctions. Am J Physiol 2001; 280: G1280–G1288.